About
Yvan Renaud has been appointed CEO of Symbiotics Group effective spring 2025, following more than two decades with the company in roles including Head of Research & Advisory, Chief Risk Officer, Chief Operating Officer, and CEO of Symbiotics Investments since 2022. He succeeds founder Roland Dominicé and leads the firm through its transformation from a specialized impact investment firm to a comprehensive market access platform for institutional investors in emerging and frontier markets.
Invests in
FintechImpact & Social Good
Colleagues at Symbiotics
Frequently asked questions
- Who is Yvan Renaud?
- Yvan Renaud has been appointed CEO of Symbiotics Group effective spring 2025, following more than two decades with the company in roles including Head of Research & Advisory, Chief Risk Officer, Chief Operating Officer, and CEO of Symbiotics Investments since 2022. He succeeds founder Roland Dominicé and leads the firm through its transformation from a specialized impact investment firm to a comprehensive market access platform for institutional investors in emerging and frontier markets.
- Where does Yvan Renaud work?
- Yvan Renaud is CEO of Symbiotics Group at Symbiotics.
- What does Yvan Renaud invest in?
- Yvan Renaud invests in Fintech, Impact & Social Good.